Results 231 to 240 of about 1,985,411 (290)

Drug-drug interactions with pioglitazone, losartan, and midazolam and anti-tumor efficacy and safety study of TAS-115 in patients with solid tumors. [PDF]

Cancer Chemother Pharmacol
Katsuya Y, Takenaka S, Takahashi S, Yamamoto N.   +3 more
europepmc   +1 more source

Comparing the Effect of Semi‐Immersive Virtual Reality, Computerized Cognitive Training, and Traditional Rehabilitation on Cognitive Function in Multiple Sclerosis: A Randomized Clinical Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio, Desiree Latella, Lilla Bonanno, Paulo Cezar Rocha dos Santos, Marcos Maldonado‐Díaz, Meir Plotnik, Rosaria De Luca, Angelo Quartarone, Rocco Salvatore Calabrò   +8 more
wiley   +1 more source

Prevalence and Duration of Potential Drug-Drug Interactions Among US Nursing Home Residents, 2018-2020. [PDF]

J Am Geriatr Soc
Reich LA, Daiello LA, Berry SD, D'Amico AM, Kiel DP, Harris DA, Hayes KN, Leonard CE, Hsu YS, Zullo AR.   +9 more
europepmc   +1 more source

White Matter Hyperintensity Burden and Short‐Interval Change Associated With Sleep Apnoea in the UK Biobank

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background and Purpose White matter hyperintensities (WMH) are a core neuroimaging marker of cerebral small vessel disease (CSVD). Sleep apnoea (SA) is a recognized vascular risk factor, but its associations with regional WMH burden, short‐interval WMH change and cognitive performance in population‐based cohorts remain incompletely defined. We
Peng Cheng, Diego Z. Carvalho, Shahid Karim, Anwar Chahal, Virend K. Somers   +4 more
wiley   +1 more source

Polypharmacy and potential drug-drug interactions among older patients: A cross-sectional baseline study pre-2023 Palestine crisis. [PDF]

Sci Prog
Mosleh R, Jarrar Y, Qadous SG, Ghanim M.
europepmc   +1 more source

Prevalence of OATP1B-Mediated Drug-Drug Interactions in an Academic Medical Center. [PDF]

Clin Transl Sci
Bories M, Malnoë D, Le Corre P.
europepmc   +1 more source

Risk prediction model for severe potential drug-drug interactions in colorectal cancer patients: a real-world data study. [PDF]

Front Pharmacol
Pei X, Yang X, Kong L.
europepmc   +1 more source

Tracing the evolution of polypharmacy and contraindicated drug‒drug interactions in people living with HIV in Belgium. [PDF]

Front Pharmacol
Lopez Delhoulle V, Destordeur LC, Maes N, Fombellida K, El Moussaoui M, Darcis G.   +5 more
europepmc   +1 more source